Clinical trial
ART Drug Dosage Adjustment Using FSCII in Chinese HIV-infected Population
NCT02632474 is registered in ClinicalTrials.gov with Shanghai Public Health Clinical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ART Drug Dosage Adjustment Using FSCII in Chinese HIV-infected Population
- Lead sponsor
- Shanghai Public Health Clinical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2015
- Completion date
- Not reported
- Enrollment
- 10 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.